ArticleMolecular cancer2025

Profiling triple-negative breast cancer-specific super-enhancers identifies high-risk mesenchymal development subtype and BETi-Targetable vulnerabilities.

Qing-Shan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.